Advanced search
Publication Cover
Drug Delivery Volume 25, 2018 - Issue 1
Submit an article Journal homepage
2,397
Views
30
CrossRef citations to date
0
Altmetric
Research Article

HSA-based multi-target combination therapy: regulating drugs’ release from HSA and overcoming single drug resistance in a breast cancer model

Yi GouState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Science and Technology of China, Guangxi Normal University, Guilin, Guangxi, China; ;School of Pharmacy, Nantong University, Nantong, Jiangsu, China; View further author information
,
Zhenlei ZhangState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Science and Technology of China, Guangxi Normal University, Guilin, Guangxi, China; View further author information
,
Dongyang LiDepartment of Biology, Southern University of Science and Technology, Shenzhen, Guangdong, China; View further author information
,
Lei ZhaoState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Science and Technology of China, Guangxi Normal University, Guilin, Guangxi, China; View further author information
,
Meiling CaiState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Science and Technology of China, Guangxi Normal University, Guilin, Guangxi, China; View further author information
,
Zhewen SunState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Science and Technology of China, Guangxi Normal University, Guilin, Guangxi, China; View further author information
,
Yongping LiState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Science and Technology of China, Guangxi Normal University, Guilin, Guangxi, China; View further author information
,
Yao ZhangState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Science and Technology of China, Guangxi Normal University, Guilin, Guangxi, China; View further author information
,
Hamid KhanState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Science and Technology of China, Guangxi Normal University, Guilin, Guangxi, China; View further author information
,
Hongbing SunState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Science and Technology of China, Guangxi Normal University, Guilin, Guangxi, China; ;Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, China Pharmaceutical University, Nanjing, Jiangsu, ChinaView further author information
,
Tao WangDepartment of Biology, Southern University of Science and Technology, Shenzhen, Guangdong, China; Correspondence[email protected]
View further author information
,
Hong LiangState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Science and Technology of China, Guangxi Normal University, Guilin, Guangxi, China; Correspondence[email protected]
View further author information
&
Feng YangState Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Science and Technology of China, Guangxi Normal University, Guilin, Guangxi, China; Correspondence[email protected]
View further author information
 show all
Pages 321-329 | Received 21 Nov 2017, Accepted 11 Jan 2018, Published online: 19 Jan 2018

Citations (30)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Navid Rabiee, Sepideh Ahmadi, Zeynab Arab, Mojtaba Bagherzadeh, Moein Safarkhani, Behzad Nasseri, Mohammad Rabiee, Mohammadreza Tahriri, Thomas J Webster & Lobat Tayebi. (2020) Aptamer Hybrid Nanocomplexes as Targeting Components for Antibiotic/Gene Delivery Systems and Diagnostics: A Review. International Journal of Nanomedicine 15, pages 4237-4256.
Read now
Meng Lei, Guanglan Ma, Sijia Sha, Xueyuan Wang, Haiting Feng, Yongqiang Zhu & Xiao Du. (2019) Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance. Drug Delivery 26:1, pages 262-272.
Read now

Articles from other publishers (28)

Xing-Guo Tang, Ke Lin, Shun-Wen Guo, Yi Rong, Dan Chen, Zhe-Sheng Chen, Feng-Feng PingJin-Quan Wang. (2023) The Synergistic Effect of Ruthenium Complex Δ-Ru1 and Doxorubicin in a Mouse Breast Cancer Model. Recent Patents on Anti-Cancer Drug Discovery 18:2, pages 174-186.
Crossref
Tongfu Yang, Zhenlei Zhang, Juzheng Zhang, Yanping Li, Wenjuan Li, Hong Liang & Feng Yang. (2022) Developing a Gallium(III) Agent Based on the Properties of the Tumor Microenvironment and Lactoferrin: Achieving Two-Agent Co-delivery and Multi-targeted Combination Therapy of Cancer. Journal of Medicinal Chemistry 66:1, pages 793-803.
Crossref
Pejman Molaei, Hanie Mahaki, Hamed Manoochehri & Hamid Tanzadehpanah. (2022) Binding Sites of Anticancer Drugs on Human Serum Albumin (HSA): A Review. Protein & Peptide Letters 29:8, pages 651-675.
Crossref
Lingying Tong, Weichao Sun, Shiyong Wu & Yong Han. (2022) Characterization of Caerulomycin A as a dual-targeting anticancer agent. European Journal of Pharmacology 922, pages 174914.
Crossref
Ana Beatriz M.L.A. Tavares & Eudenilson L. Albuquerque. (2022) A Quantum Chemistry Approach of Breast Cancer Drugs Bound to Human Serum Albumin. Advanced Theory and Simulations 5:5, pages 2100464.
Crossref
F. M. Valojerdi, A. Farasat & N. Gheibi. (2022) In vitro and In silico Assessment of Human Serum Albumin Interactions with Omega 3-6-9 Fatty Acids. Journal of Applied Spectroscopy 88:6, pages 1291-1303.
Crossref
Rui Zhang, Ge Cheng, Shengnan Liu, Hongying Lv & Juan Li. (2021) A four-in-one pure nanomedicine for synergistic multi-target therapy against breast cancer. Journal of Materials Chemistry B 9:42, pages 8809-8822.
Crossref
Yi Gou, GuoJin Huang, Jinlong Li, Feng Yang & Hong Liang. (2021) Versatile delivery systems for non-platinum metal-based anticancer therapeutic agents. Coordination Chemistry Reviews 441, pages 213975.
Crossref
Amélia Galdino Ribeiro, Josival Emanuel Ferreira Alves, José Cleberson Santos Soares, Keriolaine Lima dos Santos, Íris Trindade Tenório Jacob, Cindy Juliane da Silva Ferreira, Jéssica Celerino dos Santos, Rafael David Souto de Azevedo, Sinara Mônica Vitalino de Almeida & Maria do Carmo Alves de Lima. (2021) Albumin roles in developing anticancer compounds. Medicinal Chemistry Research 30:8, pages 1469-1495.
Crossref
Meiru Song, Wei Fu, Yichang Liu, Huiqiao Yao, Ke Zheng, Lin Liu, Jinping Xue, Peng Xu, Yayu Chen, Mingdong Huang & Jinyu Li. (2021) Unveiling the molecular mechanism of pH-dependent interactions of human serum albumin with chemotherapeutic agent doxorubicin: A combined spectroscopic and constant-pH molecular dynamics study. Journal of Molecular Liquids 333, pages 115949.
Crossref
Nicolas Bondon, Laurence Raehm, Clarence Charnay, Rabah Boukherroub & Jean-Olivier Durand. (2020) Nanodiamonds for bioapplications, recent developments. Journal of Materials Chemistry B 8:48, pages 10878-10896.
Crossref
Yong Ling, Ji Liu, Jianqiang Qian, Chi Meng, Jing Guo, Weijie Gao, Biao Xiong, Changchun Ling & Yanan Zhang. (2020) Recent Advances in Multi-target Drugs Targeting Protein Kinases and Histone Deacetylases in Cancer Therapy. Current Medicinal Chemistry 27:42, pages 7264-7288.
Crossref
Ting Yang, Xin Sui, Bing Yu, Youqing Shen & Hailin Cong. (2020) Recent Advances in the Rational Drug Design Based on Multi-target Ligands. Current Medicinal Chemistry 27:28, pages 4720-4740.
Crossref
Omid Abazari, Zahra Shafaei, Adele Divsalar, Mahboubeh Eslami-Moghadam, Behafarid Ghalandari, Ali Akbar Saboury & Ali Moradi. (2020) Interaction of the synthesized anticancer compound of the methyl-glycine 1,10-phenanthroline platinum nitrate with human serum albumin and human hemoglobin proteins by spectroscopy methods and molecular docking. Journal of the Iranian Chemical Society 17:7, pages 1601-1614.
Crossref
Azadeh Hekmat, Fariba Salavati & Saeed Hesami Tackallou. (2020) The Effects of Paclitaxel in the Combination of Diamond Nanoparticles on the Structure of Human Serum Albumin (HSA) and Their Antiproliferative Role on MDA-MB-231cells. The Protein Journal 39:3, pages 268-283.
Crossref
Hend Nawara, Said Afify, Ghmkin Hassan, Maram Zahra, Marwa Atallah, Hager Mansour, Hagar Abu Quora, Md Alam, Amira Osman, Hiroki Kakuta, Hiroki Hamada, Akimasa Seno & Masaharu Seno. (2020) Paclitaxel and Sorafenib: The Effective Combination of Suppressing the Self-Renewal of Cancer Stem Cells. Cancers 12:6, pages 1360.
Crossref
Zhenlei Zhang, Juzheng Zhang, Ming Jiang, Lei Zhao, Shanhe Li, Hongbin Sun, Feng Yang & Hong Liang. (2020) Human Serum Albumin-Based Dual-Agent Delivery Systems for Combination Therapy: Acting against Cancer Cells and Inhibiting Neovascularization in the Tumor Microenvironment. Molecular Pharmaceutics 17:4, pages 1405-1414.
Crossref
Xiao Li, Ke Du, Jian Sun & Fude Feng. (2019) Apoferritin as a Carrier of Cu(II) Diethyldithiocarbamate and Biomedical Application for Glutathione-Responsive Combination Chemotherapy. ACS Applied Bio Materials 3:1, pages 654-663.
Crossref
Zaved Hazarika & Anupam Nath Jha. (2019) Computational Analysis of the Silver Nanoparticle–Human Serum Albumin Complex. ACS Omega 5:1, pages 170-178.
Crossref
Massimiliano Cuccioloni, Laura Bonfili, Valentina Cecarini, Massimo Nabissi, Riccardo Pettinari, Fabio Marchetti, Riccardo Petrelli, Loredana Cappellacci, Mauro Angeletti & Anna Maria Eleuteri. (2019) Exploring the Molecular Mechanisms Underlying the in vitro Anticancer Effects of Multitarget‐Directed Hydrazone Ruthenium(II)–Arene Complexes. ChemMedChem 15:1, pages 105-113.
Crossref
Fereshte Valojerdi, Alireza Farasat, Hanifeh Shariatifar & Nematollah Gheibi. (2019) Study of HSA interactions with arachidonic acid using spectroscopic methods revealing molecular dynamics of HSA‑AA interactions. Biomedical Reports.
Crossref
Yong Ling, Wei-Jie Gao, Changchun Ling, Ji Liu, Chi Meng, Jianqiang Qian, Siqun Liu, Huiling Gan, Hongmei Wu, Jinhua Tao, Hong Dai & Yanan Zhang. (2019) β-Carboline and N-hydroxycinnamamide hybrids as anticancer agents for drug-resistant hepatocellular carcinoma. European Journal of Medicinal Chemistry 168, pages 515-526.
Crossref
Zhe Jin, Miao Chi, Quan He, Yuanjiang Pan & Cuirong Sun. (2019) Perfluoroalkane sulfonyl fluorides non-covalently bind to human serum albumin at Sudlow’s sites. Toxicology Letters 301, pages 17-23.
Crossref
Bo Tang, Yu Qian, Yi Gou, Gang Cheng & Guihua Fang. (2018) VE-Albumin Core-Shell Nanoparticles for Paclitaxel Delivery to Treat MDR Breast Cancer. Molecules 23:11, pages 2760.
Crossref
Jungang Deng, Ping Yu, Zhenlei Zhang, Jun Wang, Jinhua Cai, Na Wu, Hongbin Sun, Hong Liang & Feng Yang. (2018) Designing anticancer copper(II) complexes by optimizing 2-pyridine-thiosemicarbazone ligands. European Journal of Medicinal Chemistry 158, pages 442-452.
Crossref
Feng Yang & Hong Liang. (2018) Designing anticancer multitarget metal thiosemicarbazone prodrug based on the nature of binding sites of human serum albumin carrier. Future Medicinal Chemistry 10:16, pages 1881-1883.
Crossref
Jun Wang, Yi Gou, Zhenlei Zhang, Ping Yu, Jinxu Qi, Qipin Qin, Hongbin Sun, Xiaoyang Wu, Hong Liang & Feng Yang. (2018) Developing an Anticancer Copper(II) Multitarget Pro-Drug Based on the His146 Residue in the IB Subdomain of Modified Human Serum Albumin. Molecular Pharmaceutics 15:6, pages 2180-2193.
Crossref
Maria J Matos. (2018) Learning from nature: the role of albumin in drug delivery. Future Medicinal Chemistry 10:9, pages 983-985.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.